NIH Public Relations Spending Probe

Republicans seek to evaluate the agency’s spending on communications.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, 401(K) 2013Seven Republican congress members have requested information from the National Institutes of Health (NIH) on its communications spending. In a letter sent last week (April 12) to NIH Director Francis Collins, the congressmen and women said that “[g]iven the need for the NIH to find ways to control spending,” they would like to examine the agency’s communications expenditures since the 2010 fiscal year. “With increasingly tight Federal budgets, every dollar invested at the NIH becomes even more precious,” the letter read.

The letter also cited an editorial published in Nature last month (March 13) censuring the NIH’s National Cancer Institute (NCI) for its Office of Communications and Education budget, which an investigation by The Cancer Letter published in December revealed to have been $45 million in 2012. This is “almost double what the Food and Drug Administration spent on communications, including drug and food safety announcements,” last week’s letter pointed out.

The offending NCI budget funds pamphlet publication and distribution, the NCI website, surveys, special events, and more, The Cancer Letter said. Additional NCI offices take care of other outside communications, including interacting with the press, and have a combined budget of $7 million.

The Cancer Letter said it had not been able to get information ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies